Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

STEVANATO Aktie

 >STEVANATO Aktienkurs 
21.1 EUR    (Tradegate)
Ask: 21.2 EUR / 235 Stück
Bid: 21 EUR / 239 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
STEVANATO Aktie über LYNX handeln
>STEVANATO Performance
1 Woche: 0%
1 Monat: +7,9%
3 Monate: +21,3%
6 Monate: -8,3%
1 Jahr: +27,5%
laufendes Jahr: +2,4%
>STEVANATO Aktie
Name:  STEVANATO GROUP SPA O.N.
Land:  Italien
Sektor:  Gesundheit
ISIN/ Wkn:  IT0005452658 / A3CUMB
Symbol/ Ticker:  87N (Frankfurt) / STVN (NYSE)
Kürzel:  FRA:87N, ETR:87N, 87N:GR, NYSE:STVN
Index:  -
Webseite:  https://www.stevanatogrou..
Marktkapitalisierung:  5660 Mio. EUR
Umsatz:  1120 Mio. EUR
EBITDA:  243.86 Mio. EUR
Gewinn je Aktie:  0.46 EUR
Schulden:  394.47 Mio. EUR
Liquide Mittel:  91.13 Mio. EUR
Umsatz-/ Gewinnwachstum:  8.7% / 40.9%
KGV/ KGV lG:  44.78 / 39.06
KUV/ KBV/ PEG:  5 / 3.97 / -
Gewinnm./ Eigenkapitalr.:  11.16% / 9.14%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / 0.26%
Div. Historie:  04.06.24 - 0.053€
13.06.22 - 0.05189€
Insiderhandel:  -
Suchwörter:  STEVANATO
Letzte Datenerhebung:  06.07.25
>STEVANATO Eigentümer
Aktien: 49.6 Mio. St.
f.h. Aktien: 48.81 Mio. St.
Insider Eigner: 1.68%
Instit. Eigner: 112.69%
>STEVANATO Peer Group

 
03.06.25 - 23:51
XFRA: DIVIDEND/INTEREST INFORMATION - 05.06.2025 - EQUBF_01 (XETRA)
 
Das Instrument 87N IT0005452658 STEVANATO GROUP SPA O.N. EQUITY wird cum Dividende/Zinsen gehandelt am 04.06.2025 und ex Dividende/Zinsen am 05.06.2025 The instrument 87N IT0005452658 STEVANATO GROUP SPA O.N. EQUITY has its pre-dividend/interest day on 04.06.2025 and its ex-dividend/interest day on 05.06.2025...
08.05.25 - 15:00
Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates (Zacks)
 
Stevanato (STVN) delivered earnings and revenue surprises of 10% and 0.23%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
08.05.25 - 13:00
Stevanato Group Non-GAAP EPS of €0.10 in-line, revenue of €256.6M misses by €23.36M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.05.25 - 12:42
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025 (Business Wire)
 
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the first quarter of 2025. First Quarter 2025 Highlights (comparisons to prior-year period) Revenue for the first quarter of 2025 increased 9% to €256.6 million, and high-value solutions represented 43% of total revenue. Gross profit margin increased 80 basis points to 27.2%. Diluted earnings per share were €0.10, and adjusted diluted earnings per share were €0.10. Adjusted EBITDA margin increased 100 basis points to 22.4%. The Company is maintaining its fiscal 2025 revenue guidance of €1,160 million to €1,190 million, and is updating its guidance for adjusted EBITDA and adjusted diluted earnings per share to reflect the expected impact from tariffs. As a result, the Company now expects adjusted EBITDA in the range of €288.5 ...
05.05.25 - 11:54
Stevanato Group declares $0.0613 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.04.25 - 23:18
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
 
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2025 on Thursday, May 8, 2025, at 6:30 a.m. (ET). Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Thursday, May 8, 2025, to discuss financial results. During the call, management will refer to a slide presentation, which will be available on the morning of the call on the “Financial Results” page under the Company's Investor Relations section of its website. Pre-registration: Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. We encourage participants to pre-register for the conference call using the following link: STVN conference call pre-registra...
07.03.25 - 14:45
Stevanato Group reports Q4 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.03.25 - 15:15
Stevanato Group (STVN) Meets Q4 Earnings Estimates (Zacks)
 
Stevanato (STVN) delivered earnings and revenue surprises of 0% and 1.85%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
06.03.25 - 12:39
Stevanato Group Non-GAAP EPS of €0.19, revenue of €330.6M; initiates FY25 outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.03.25 - 12:33
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024 (Business Wire)
 
- Introduces 2025 Guidance - PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter and fiscal year 2024. Fourth Quarter and Full-Year 2024 Highlights (comparisons to prior-year period) Revenue for the fourth quarter of 2024 increased 3% to €330.6 million, and high-value solutions represented 40% of total revenue, in line with Company expectations. For the fourth quarter, diluted earnings per share were €0.18, and adjusted diluted earnings per share were €0.19. Adjusted EBITDA margin increased 50 basis points to 27.5% for the fourth quarter. For fiscal year 2024, revenue increased 2% to €1,104 million, and high-value solutions represented 38% of total revenue. For fiscal year 2024, diluted earnings per share were €0.43, and adjusted diluted earnings per share wer...
24.02.25 - 22:03
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025 (Business Wire)
 
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the fourth quarter and fiscal year 2024 on Thursday, March 6, 2025, at 6:30 a.m.(ET). Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Thursday, March 6, 2025, to discuss financial results. During the call, management will refer to a slide presentation that will be available on the morning of the call on the “Financial Results” page under the Company's Investor Relations section of its website. Pre-registration: Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants are encouraged to pre-register for the conference call using the following link: STVN conference c...
29.11.24 - 17:30
S&P 500 Futures Rise in Premarket Trading; Stevanato Group, XP Lag (MarketWatch)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.24 - 15:03
Stevanato Group (STVN) Q3 Earnings Match Estimates (Zacks)
 
Stevanato (STVN) delivered earnings and revenue surprises of 0% and 1.89%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?...
05.11.24 - 14:45
Stevanato Group Non-GAAP EPS of EUR 0.12, revenue of EUR 277.9M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.24 - 12:50
Stevanato Group Reports Financial Results for the Third Quarter of 2024 (Business Wire)
 
Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.24 - 23:15
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024 (Business Wire)
 
Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.24 - 17:19
Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for (Zacks)
 
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
01.10.24 - 12:39
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan (Business Wire)
 
Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...
26.09.24 - 13:08
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU” (Business Wire)
 
Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...
26.09.24 - 12:44
Gerresheimer, Stevanato Group And Schott Pharma Announce Strategic Industry "Alliance For RTU" (Reuters EN)
 
Gerresheimer, Stevanato Group And Schott Pharma Announce Strategic Industry "Alliance For RTU"...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Männer sind wie Luft, zwar versaut, aber unentbehrlich. - Michelle Pfeiffer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!